Predictors of efficacy of corticosteroid switching from abiraterone plus prednisone to dexamethasone in patients with metastatic castration-resistant prostate cancer

Predictors of efficacy of corticosteroid switching from abiraterone plus prednisone to dexamethasone in patients with metastatic castration-resistant prostate cancer

Corticosteroid switching can reverse abiraterone resistance in some patients with metastatic castration-resistant prostate cancer (mCRPC). Here, we investigated the potential biomarkers for predicting the efficacy of corticosteroid switching during treatment with abiraterone acetate (AA). We retrosp...

Full description

Bibliographic Details
Main Authors: Yu-Chao Ni, Jin-Ge Zhao, Meng-Ni Zhang, Yi-Jun Zhang, Zhen-Yu Yang, Ni Chen, Jun-Ru Chen, Peng-Fei Shen, Guang-Xi Sun, Xing-Ming Zhang, Yong-Hong Li, Hao Zeng
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Asian Journal of Andrology
Subjects:
abiraterone acetate; alkaline phosphatase; corticosteroid switching; dexamethasone; metastatic castration-resistant prostate cancer
Online Access:http://www.ajandrology.com/article.asp?issn=1008-682X;year=2022;volume=24;issue=2;spage=154;epage=160;aulast=

Internet

http://www.ajandrology.com/article.asp?issn=1008-682X;year=2022;volume=24;issue=2;spage=154;epage=160;aulast=

Similar Items